The global Clinical Diagnostics market is anticipated to grow at a CAGR of 6.3% during the forecast period (2023–2030). The market’s growth can be attributed to the rising prevalence of chronic and infectious diseases, along with to the growing adoption of automated platforms. In 2021, according to the World Health Organization (WHO), approximately 400,000 children and adolescents aged 0 to 19 were diagnosed with cancer. Among them, leukemia, brain tumors, lymphomas, and solid tumors like neuroblastomas and Wilms tumors were the most common. Additionally, the International Agency for Research on Cancer (IARC) noted in December 2020 that the global cancer burden had risen significantly, with 19.3 million cases reported.
Browse the full report description of “Clinical Diagnostics Market Size, Share & Trends Analysis Report by Test (Lipid Panel, Liver Panel, Renal Panel, Complete Blood Count, Electrolyte Testing, Infectious Disease Testing, and Others), by Product (Instruments, Reagents, and Others), and by End-User (Hospital Laboratory, Diagnostic Laboratory, and Point-of-Care Testing), Forecast Period (2023-2030)” at https://www.omrglobal.com/industry-reports/clinical-diagnostics-market
The high demand for effective clinical diagnostics has fueled market. Furthermore, the increasing prevalence of infectious diseases is anticipated to contribute to the expansion of the clinical diagnostics market. For instance, in July 2023, the WHO states that a considerable number of sexually transmitted infections are contracted globally daily, with majority cases showing no symptoms. Every year, around 374 million new cases of treatable infections such as chlamydia, gonorrhea, syphilis, and trichomoniasis, are reported. The rising prevalence of chronic conditions has created a demand for healthcare systems, and clinical diagnostics play a pivotal role in disease prevention, detection, and management. This factor is expected to drive the growth of the market.
Market Coverage
• The market number available for – 2022-2030
• Base year- 2022
• Forecast period- 2023-2030
• Segment Covered-
o By Test
o By Product
o By End-User
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- includes Abbott, Cepheid, Charles River Laboratories International, Inc., Exact Sciences Corp., Flagship Biosciences, Inc., and others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Clinical Diagnostics Market Report Segment
By Test
By Product
By End-User
Global Clinical Diagnostics Market Report Segment by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/clinical-diagnostics-market